Phase
Startup
Strike Pharma
Next-generation precision medicine
Strike Pharma has developed a technology platform that enables the selective delivery of drugs, enclosed in nanoparticles, to specific cells in the body. With this innovation, immune cells can be reprogrammed inside the body (in vivo), which would offer significant advantages in treating autoimmune diseases and cancer.
This approach supports the development of next-generation CAR-T therapies – an advanced form of immunotherapy where a patient’s T cells (a type of immune cells) are reprogrammed to recognize and eliminate harmful cells.
Currently, Strike Pharma is developing a drug candidate that reprograms T cells to attack B cells, aiming to improve treatments for certain autoimmune diseases.
Per Norlén brings extensive experience to the company, in leading innovative biotech companies. He has previously served as CEO of Alligator Bioscience, Targinta, Evaxion Biotech, and WntResearch.
Did you know?
New technologies for next-gen antibody therapeutics
Single Molecule Nanowire Biosensors for Diagnostics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Early cancer detection through chemical signature preserved in hair
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Rapid analyses of human genetic variants
Nanosystems for oral biologics delivery
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Next-generation precision medicine
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
